Alpha Cognition Inc.

ACOG ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2026 FY2025 FY2024 FY2023
Revenue $10.2M
Cost of Revenue $603.4K
Gross Profit $9.6M
Gross Margin 94.1%
Operating Expenses
Research & Development $1.9M $3.9M $4.9M
SG&A Expense $29.1M $8.0M $5.1M
Operating Income $-22.7M $-12.0M $-9.9M
Operating Margin -221.7%
Interest Expense
Pretax Income
Income Tax Expense
Net Income $-20.7M $-14.8M $-13.8M
Net Margin -202.2%
EPS (Basic) $-1.17 $-1.02 $-0.96
EPS (Diluted) $-1.18 $-1.02 $-0.96
Shares Outstanding (Basic) 21.8M 17.7M 14.5M 14.3M
Shares Outstanding (Diluted) 21.8M 17.7M 14.5M 14.3M
Dividends Per Share